Global and Region Gastro Esophageal Reflux Disease (GERD) Drug Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Gastro Esophageal Reflux Disease (GERD) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastro Esophageal Reflux Disease (GERD) Drugmarket, defines the market attractiveness level of Gastro Esophageal Reflux Disease (GERD) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastro Esophageal Reflux Disease (GERD) Drug industry, describes the types of Gastro Esophageal Reflux Disease (GERD) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastro Esophageal Reflux Disease (GERD) Drug market and the development prospects and opportunities of Gastro Esophageal Reflux Disease (GERD) Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastro Esophageal Reflux Disease (GERD) Drug market in Chapter 13.

    By Player:

    • Merck

    • Novartis AG

    • GlaxoSmithKline

    • Pfizer

    • Medtronic

    By Type:

    • H2 Receptor Antagonist

    • Proton Pump Inhibitor (PPi)

    • Antacids

    By End-User:

    • Hospital

    • Clinic

    • Medical Center

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastro Esophageal Reflux Disease (GERD) Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastro Esophageal Reflux Disease (GERD) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastro Esophageal Reflux Disease (GERD) Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastro Esophageal Reflux Disease (GERD) Drug Market Analysis and Outlook to 2022

    • 7.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Consumption (2017-2022)

    • 7.2 United States Gastro Esophageal Reflux Disease (GERD) Drug Consumption (2017-2022)

    • 7.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Consumption (2017-2022)

    • 7.4 China Gastro Esophageal Reflux Disease (GERD) Drug Consumption (2017-2022)

    • 7.5 Japan Gastro Esophageal Reflux Disease (GERD) Drug Consumption (2017-2022)

    • 7.6 India Gastro Esophageal Reflux Disease (GERD) Drug Consumption (2017-2022)

    • 7.7 South Korea Gastro Esophageal Reflux Disease (GERD) Drug Consumption (2017-2022)

    8 Region and Country-wise Gastro Esophageal Reflux Disease (GERD) Drug Market Analysis and Outlook to 2028

    • 8.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast (2022-2028)

    • 8.2 United States Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast (2022-2028)

    • 8.4 China Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast (2022-2028)

    • 8.6 India Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast (2022-2028)

    9 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global H2 Receptor Antagonist Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Proton Pump Inhibitor (PPi) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antacids Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Medical Center Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global H2 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Proton Pump Inhibitor (PPi) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Antacids Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Medical Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastro Esophageal Reflux Disease (GERD) Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Competitive Analysis

    • 14.1 Merck

      • 14.1.1 Merck Company Details

      • 14.1.2 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    • 14.2 Novartis AG

      • 14.2.1 Novartis AG Company Details

      • 14.2.2 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    • 14.3 GlaxoSmithKline

      • 14.3.1 GlaxoSmithKline Company Details

      • 14.3.2 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    • 14.5 Medtronic

      • 14.5.1 Medtronic Company Details

      • 14.5.2 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastro Esophageal Reflux Disease (GERD) Drug

    • Figure Gastro Esophageal Reflux Disease (GERD) Drug Picture

    • Table Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastro Esophageal Reflux Disease (GERD) Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastro Esophageal Reflux Disease (GERD) Drug Consumption by Country (2017-2022)

    • Figure United States Gastro Esophageal Reflux Disease (GERD) Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Gastro Esophageal Reflux Disease (GERD) Drug Consumption and Growth Rate (2017-2022)

    • Figure China Gastro Esophageal Reflux Disease (GERD) Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastro Esophageal Reflux Disease (GERD) Drug Consumption and Growth Rate (2017-2022)

    • Figure India Gastro Esophageal Reflux Disease (GERD) Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastro Esophageal Reflux Disease (GERD) Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastro Esophageal Reflux Disease (GERD) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global H2 Receptor Antagonist Consumption and Growth Rate (2017-2022)

    • Figure Global Proton Pump Inhibitor (PPi) Consumption and Growth Rate (2017-2022)

    • Figure Global Antacids Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Center Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global H2 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Proton Pump Inhibitor (PPi) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antacids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastro Esophageal Reflux Disease (GERD) Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastro Esophageal Reflux Disease (GERD) Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product and Service

    • Table Medtronic (Foundation Year, Company Profile and etc.)

    • Table Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.